Cellular

From machines to animals to humans

Exclusive with Prof Joao Pedro de Magalhaes: talking AI, indication expansion and animal models. “Will you still need me, will you still feed me, when...

Some good news: announcing Longevity2020

In these challenging times, with everyone working from home and conferences pushed-back to later this year, we had an idea: Longevity2020 While the world overcomes...

‘Damage-eating’ protein fixes DNA harmed by aging

A toolkit of proteins that can repair breaks in strands of DNA has been discovered by scientists at the Universities of Sheffield and Oxford. DNA...

Two novel anti-aging targets identified

A recent Chinese study has identified two novel anti-aging targets that accelerate aging by suppressing the expression of genes involved in mitochondrial function maintenance: promoting...

Better, faster, stronger CRISPR

Cytosurge claims to be able to make CRISPR “better and faster than anybody else on single cell level” - seeking investment to evolve world’s smallest syringe...

The Reason behind Longevity: start-up opportunities

We connected with Reason (the person) to get the inside track on hot areas for Longevity R&D.   Longevity.Technology: Advocacy runs through Reason like a...

114 year-old cells converted to pluripotent stem cells

AgeX publishes evidence of supercentenarian cellular age reversal: new paper supports hypothesis of no upper age limit for reprogramming cellular aging. This is big...

Placenta blood and personalised Longevity therapies

The placenta is a reservoir of stem cells with minimal ethical concerns. The establishment of placental stem cell biobanks will enable their use in...

Proving the Longevity potential of NAD+

Talking sirtuins, NAD+ and trials with Elysium Health CEO Eric Marcotulli. When it comes to the world of consumer anti-aging supplements, there are few higher-profile...

Fishing for regenerative therapies

Talking Longevity, indication expansion, killifish and regeneration with Dr Aric Rogers from the MDI Biological Laboratory. Nestled on the picturesque coastline of Maine, USA, the...

Pathway to Longevity: get rid of zombie cells

Understanding the trigger for cellular senescence could help to forge new treatments for Longevity, stopping aging before it's started. Cellular senescence is a double-edged sword;...

FDA-approved drug slows cellular aging

Scientists in the USA have discovered a drug to slow the cellular aging process. The only problem is its toxic side effects. Ah. Scientists at...

Hormone producing organoids to halt age-related disease

JangoBio claims a scientific breakthrough in developing sustainable stem-cell based organoids for hormone restoration. Having recently closed a $2m seed round, researchers at JangoBio's Wisconsin...

Human CRISPR trial heralds Longevity success

Trial finds not only that gene-edited immune cells are safe, but that they survive and thrive after being placed into patients suffering from advanced...

Triggering immune cells could slow brain aging

It’s often accepted that as we age we will suffer the odd “slip of memory”. But, new research could pave the way for further...

J&J enters Longevity market with “Immorbidity” play

A new competition aims to find the next great breakthrough to help us stay active and healthy beyond the age of 100. People are living...

Rejuvenate Bio teaches old dogs new tricks

A combination gene therapy developed by the Wyss Institute and Harvard Medical School is set to treat several age-related conditions in dogs, extending their...

AgeX and UCI collaborate on neurological disorder

Research partnership announced on neural stem cell research program for Huntington’s disease and other conditions. Hot on the heels of announcing a partnership with a...

Biosens raising £5m to support commercialisation

Start-up targets cell senescence therapies and near-term opportunities in advanced cosmetics market. The market for the development of anti-senescence therapeutics is on fire and we’ve...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

Latest articles

Longevity 2020: shaping-up nicely

Over 45 confirmed speakers for this 5-day online event and a big thank you for your interest. We're moving fast! Longevity 2020 started just over...

Telomeres on repeat to inhibit inflamm-aging

Coming around again – Italian team hopes to use repeated nucleobases to delay aging through extending telomeres. Inflammation is a double-edged sword; while it is necessary...

Join me at my 100th birthday party in 2049!

We speak with GRG's Johnny Adams, a key contributor to the Longevity2020 online conference, about his quest for more healthy years. One of the speakers at this month’s...

Call for consensus in defining biological aging

We speak with a key contributor to the Longevity2020 online conference about biological aging. UK start-up AgeCurve is focused on the measurement of aging and...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.